HYPHYCA: a prospective study in 613 patients conducting a comprehensive analysis for predictive factors of physiological 18F-FDG anal uptake

Nicolas Aide, Laure-Eugénie Tainturier, Cathy Nganoa, Benjamin Houdu, Jennifer Kammerer, Marie-Pierre Galais, Renaud Ciappuccini, Charline Lasnon, Nicolas Aide, Laure-Eugénie Tainturier, Cathy Nganoa, Benjamin Houdu, Jennifer Kammerer, Marie-Pierre Galais, Renaud Ciappuccini, Charline Lasnon

Abstract

Background: Anal cancer is a relatively rare tumor of which incidence increases in developed countries. 18F-FDG PET has been increasingly used for its post radio-chemotherapy evaluation. However, several authors have reported the risk of local false-positive findings leading to low specificity and positive predictive values. These false-positive results could be due to post-radiotherapy inflammation or infection but certainly also to physiological anal canal uptake that is observed on a regular basis in clinical practice. The purpose of this prospective study (NCT03506529; HYPHYCA) was therefore to seek predictive factors of physiological anal canal hypermetabolism.

Materials and methods: Over a 2-month period, patients aged 18 years old and more, referred for 18F-FDG PET-CT at two EARL-accredited PET centers were included, after obtaining their informed and written consent. They were asked to fill in a questionnaire including seven closed questions about usual intestinal transit, ongoing medications relative to intestinal transit, history of digestive, and anal and/or pelvic diseases. Age, gender, and body mass index (BMI) were recorded. A single nuclear medicine physician visually and quantitatively analyzed anal canal uptake (SUVmax_EARL) and assessed visual rectal content (air, feces, or both) and the largest rectal diameter (mm).

Results: Six hundred and thirteen patients were included (sex ratio F/M = 0.99) and 545 (89%) questionnaires were entirely completed. Significantly more males presented anal canal hypermetabolism (sex ratio (M/F) = 1.18 versus 0.85, p = 0.048). Moreover, patients with anal canal hypermetabolism had higher BMI (27.6 (5.7) kg/m2 versus 23.9 (4.5) kg/m2, p < 0.0001), higher rate of hemorrhoid history (43% versus 27%, p = 0.016), and higher rate of rectum filled with only feces (21% versus 12%, p = 0.019) as compared to patients with no anal canal uptake. On logistic regression, all these variables were found to be independent predictors of the occurrence of an anal canal hypermetabolism. Odds ratio were 1.16 (1.12-1.20) per unit of BMI (kg/m2) (p < 0.0001), 1.48 (1.04-2.11) for males (p = 0.030), 1.64 (1.10-2.45) for hemorrhoids history (p = 0.016), and 1.94 (1.147-3.22) for the rectum filled with only feces (p = 0.010).

Conclusion: According to our study, the predictive factors of physiological anal canal hypermetabolism are high BMI, male gender, hemorrhoid history, and rectum filled with only feces. This may pave the way to a more specific interpretation of post radio-chemotherapy PET evaluations of anal canal cancer, provided that other studies are conducted in this specific population.

Trial registration: This prospective study was registered at Clinicaltrial.gov: NCT03506529; HYPHYCA on April 24, 2018.

Keywords: 18F-FDG; Anal cancer; PET; Physiological uptake.

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Additional details on PET examinations indications
Fig. 2
Fig. 2
Visual versus quantitative analysis of anal canal uptake. Data are presented as Tukey’s boxplots and o represents outliers
Fig. 3
Fig. 3
Linear regression of SUVmax_EARL and body mass index (kg/m2)
Fig. 4
Fig. 4
Illustration of rectal content classification and its association with anal canal uptake. a Empty rectum. b Air rectal content classified 0. c Fecal rectal content classified 1. d Mixed rectal content classified 2
Fig. 5
Fig. 5
Axial EARL-accredited images centered on the anal canal (left panel) and the liver (right panel) of a patient classified with significant anal canal hypermetabolism on visual analysis who would be classified “negative” using liver uptake as reference (a) and a patient classified with basal anal canal hypermetabolism who would be classified as “positive” using liver uptake as reference (b)

References

    1. Grulich AE, Poynten IM, Machalek DA, Jin F, Templeton DJ, Hillman RJ. The epidemiology of anal cancer. Sexual health. 2012;9:504–508. doi: 10.1071/sh12070.
    1. Bartelink H, Roelofsen F, Eschwege F, Rougier P, Bosset J F, Gonzalez D G, Peiffert D, van Glabbeke M, Pierart M. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. Journal of Clinical Oncology. 1997;15(5):2040–2049. doi: 10.1200/JCO.1997.15.5.2040.
    1. Goldman KE, White EC, Rao AR, Kaptein JS, Lien WW. Posttreatment FDG-PET-CT response is predictive of tumor progression and survival in anal carcinoma. Pract Radiat Oncol. 2016;6:e149–ee54. doi: 10.1016/j.prro.2016.01.004.
    1. Houard C, Pinaquy JB, Mesguich C. Henriques de Figueiredo B, Cazeau AL, Allard JB, et al. Role of (18)F-FDG PET/CT in posttreatment evaluation of anal carcinoma. Journal of nuclear medicine : official publication. Society of Nuclear Medicine. 2017;58:1414–1420. doi: 10.2967/jnumed.116.185280.
    1. Vercellino L, Montravers F, de Parades V, Huchet V, Kerrou K, Bauer P, et al. Impact of FDG PET/CT in the staging and the follow-up of anal carcinoma. Int J Colorectal Dis. 2011;26:201–210. doi: 10.1007/s00384-010-1080-9.
    1. Mistrangelo M, Pelosi E, Bello M, Ricardi U, Milanesi E, Cassoni P, et al. Role of positron emission tomography-computed tomography in the management of anal cancer. Int J Radiat Oncol Biol Phys. 2012;84:66–72. doi: 10.1016/j.ijrobp.2011.10.048.
    1. Nguyen BT, Joon DL, Khoo V, Quong G, Chao M, Wada M, et al. Assessing the impact of FDG-PET in the management of anal cancer. Radiother Oncol. 2008;87:376–382. doi: 10.1016/j.radonc.2008.04.003.
    1. Annual Congress of the European Association of Nuclear Medicine October 12 - 16, 2019 Barcelona, Spain. European journal of nuclear medicine and molecular imaging. 2019;46:1-952. doi:10.1007/s00259-019-04486-2.
    1. Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328–354. doi: 10.1007/s00259-014-2961-x.
    1. Aide N, Lasnon C, Veit-Haibach P, Sera T, Sattler B, Boellaard R. EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies. Eur J Nucl Med Mol Imaging. 2017;44:17–31. doi: 10.1007/s00259-017-3740-2.
    1. Lasnon C, Houdu B, Kammerer E, Salomon T, Devreese J, Lebasnier A, et al. Patient’s weight: a neglected cause of variability in SUV measurements? A survey from an EARL accredited PET centre in 513 patients. Eur J Nucl Med Mol Imaging. 2016;43:197–199. doi: 10.1007/s00259-015-3214-3.
    1. Frings V, van Velden FH, Velasquez LM, Hayes W, van de Ven PM, Hoekstra OS, et al. Repeatability of metabolically active tumor volume measurements with FDG PET/CT in advanced gastrointestinal malignancies: a multicenter study. Radiology. 2014;273:539–548. doi: 10.1148/radiol.14132807.
    1. Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32:920–924. doi: 10.3109/00365529709011203.
    1. Lee HR, Lim SB, Park JY. Anorectal manometric parameters are influenced by gender and age in subjects with normal bowel function. Int J Colorectal Dis. 2014;29:1393–1399. doi: 10.1007/s00384-014-1961-4.
    1. Riss S, Weiser FA, Schwameis K, Riss T, Mittlbock M, Steiner G, et al. The prevalence of hemorrhoids in adults. Int J Colorectal Dis. 2012;27:215–220. doi: 10.1007/s00384-011-1316-3.
    1. Baek JG, Kim EC, Kim SK, Jang H. Dosimetric planning study for the prevention of anal complications after post-operative whole pelvic radiotherapy in cervical cancer patients with hemorrhoids. Br J Radiol. 2015;88:20150223. doi: 10.1259/bjr.20150223.
    1. Keef KD, Cobine CA. Control of Motility in the Internal Anal Sphincter. J Neurogastroenterol Motil. 2019;25:189–204. doi: 10.5056/jnm18172.
    1. Kamimura K, Nagamachi S, Wakamatsu H, Higashi R, Ogita M, Ueno S, et al. Associations between liver (18)F fluoro-2-deoxy-D-glucose accumulation and various clinical parameters in a Japanese population: influence of the metabolic syndrome. Ann Nucl Med. 2010;24:157–161. doi: 10.1007/s12149-009-0338-1.
    1. Salomon T, Nganoa C, Gac AC, Fruchart C, Damaj G, Aide N, et al. Assessment of alteration in liver (18)F-FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score. Eur J Nucl Med Mol Imaging. 2018;45:941–950. doi: 10.1007/s00259-017-3914-y.
    1. Eskian M, Alavi A, Khorasanizadeh M, Viglianti BL, Jacobsson H, Barwick TD, et al. Effect of blood glucose level on standardized uptake value (SUV) in (18)F- FDG PET-scan: a systematic review and meta-analysis of 20,807 individual SUV measurements. Eur J Nucl Med Mol Imaging. 2019;46:224–237. doi: 10.1007/s00259-018-4194-x.
    1. Chirindel A, Alluri KC, Tahari AK, Chaudhry M, Wahl RL, Lodge MA, et al. Liver standardized uptake value corrected for lean body mass at FDG PET/CT: effect of FDG uptake time. Clin Nuclear Med. 2015;40:e17–e22. doi: 10.1097/rlu.0000000000000446.
    1. Kuhnert G, Boellaard R, Sterzer S, Kahraman D, Scheffler M, Wolf J, et al. Impact of PET/CT image reconstruction methods and liver uptake normalization strategies on quantitative image analysis. Eur J Nucl Med Mol Imaging. 2016;43:249–258. doi: 10.1007/s00259-015-3165-8.
    1. Day FL, Link E, Ngan S, Leong T, Moodie K, Lynch C, et al. FDG-PET metabolic response predicts outcomes in anal cancer managed with chemoradiotherapy. Br J Cancer. 2011;105:498–504. doi: 10.1038/bjc.2011.274.
    1. Jones M, Hruby G, Solomon M, Rutherford N, Martin J. The role of FDG-PET in the initial staging and response assessment of anal cancer: a systematic review and meta-analysis. Ann Surg Oncol. 2015;22:3574–3581. doi: 10.1245/s10434-015-4391-9.
    1. Kim BS. The 18F-FDG PET/CT finding of a condyloma acuminata mimicking primary anorectal carcinoma in an HIV-infected patient. Clin Nuclear Med. 2013;38:e402–e403. doi: 10.1097/RLU.0b013e318266cea2.
    1. Choi BC, Pak AW. A catalog of biases in questionnaires. Preventing chronic disease. 2005;2:A13.

Source: PubMed

3
Iratkozz fel